Vawter Financial Ltd. purchased a new position in AbbVie Inc. (NYSE:ABBV – Free Report) during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor purchased 1,647 shares of the company’s stock, valued at approximately $246,000. Several other hedge funds and other institutional investors have also […]
Carlson Capital Management lessened its holdings in shares of AbbVie Inc. (NYSE:ABBV – Free Report) by 7.0% during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 2,047 shares of the company’s stock after selling 153 shares during the period. Carlson Capital Management’s holdings […]
Dempze Nancy E reduced its stake in AbbVie Inc. (NYSE:ABBV – Free Report) by 6.0% in the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 1,498 shares of the company’s stock after selling 95 shares during the period. Dempze Nancy E’s holdings […]
Ancora Advisors LLC raised its position in AbbVie Inc. (NYSE:ABBV – Free Report) by 2.0% in the 3rd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 327,437 shares of the company’s stock after acquiring an additional 6,432 shares during the quarter. AbbVie accounts for […]
Ancora Advisors LLC raised its position in shares of AbbVie Inc. (NYSE:ABBV – Free Report) by 2.0% during the 3rd quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 327,437 shares of the company’s stock after acquiring an additional 6,432 shares during the quarter. AbbVie makes […]